Gollob Jared - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 16, 2024, Gollob Jared's relationship to Kymera Therapeutics, Inc. (KYMR) is Officer (Chief Medical Officer), and currently has 118,885 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KYMR insiders.
Data Source: SEC.
Gollob Jared - Insider Non-Derivative Transactions of KYMR Common Stock
Gollob Jared - Insider Non-Derivative Transactions at KYMR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 17, 2024 | Sell -- (Common Stock) | 9864 | 46.1 | 95470 |
| Jul 17, 2024 | Sell -- (Common Stock) | 13281 | 45.59 | 105604 |
| Jul 17, 2024 | M -- (Common Stock) | 23145 | 2.08 | 118885 |
| Jul 16, 2024 | Sell -- (Common Stock) | 16455 | 45.15 | 95740 |
| Jul 16, 2024 | M -- (Common Stock) | 16455 | 2.08 | 112195 |
| Mar 5, 2024 | Sell -- (Common Stock) | 216 | 43.26 | 95740 |
| Mar 5, 2024 | Sell -- (Common Stock) | 1106 | 42.39 | 95956 |
| Mar 5, 2024 | Sell -- (Common Stock) | 2022 | 41.41 | 97062 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 24375 | 0 | 99084 |
| Feb 28, 2024 | Sell -- (Common Stock) | 400 | 45 | 74709 |
| Feb 28, 2024 | M -- (Common Stock) | 400 | 2.08 | 75109 |
| Feb 10, 2024 | Sell -- (Common Stock) | 7398 | 36.09 | 74709 |
| Feb 10, 2024 | Sell -- (Common Stock) | 38739 | 35.39 | 82107 |
| Feb 10, 2024 | M -- (Common Stock) | 46137 | 2.08 | 120846 |
| Mar 3, 2023 | Sell -- (Common Stock) | 297 | 31.4 | 74709 |
| Mar 3, 2023 | Sell -- (Common Stock) | 1001 | 30.88 | 75006 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 18750 | 0 | 76007 |